MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

STERIS PLC

Chiusa

SettoreSettore sanitario

221.06 -2.98

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

220.47

Massimo

226.95

Metriche Chiave

By Trading Economics

Entrata

16M

173M

Vendite

42M

1.4B

P/E

Media del settore

36.498

63.778

EPS

2.32

Rendimento da dividendi

1.01

Margine di Profitto

12.643

Dipendenti

18,000

EBITDA

-85M

245M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+16.45% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.01%

2.39%

Utili prossimi

7 mag 2025

Prossima data del Dividendo

25 giu 2025

Prossima data del' Ex Dividendo

11 giu 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

22B

Apertura precedente

224.04

Chiusura precedente

221.06

Notizie sul Sentiment di mercato

By Acuity

26%

74%

73 / 386 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

STERIS PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 feb 2025, 21:35 UTC

Utili

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 feb 2025, 21:34 UTC

Utili

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 feb 2025, 21:34 UTC

Utili

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 feb 2025, 21:33 UTC

Utili

Steris 3Q EPS $1.75 >STE

5 feb 2025, 21:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 feb 2025, 21:30 UTC

Utili

Steris 3Q Rev $1.4B >STE

5 feb 2025, 21:30 UTC

Utili

Steris 3Q Adj EPS $2.32 >STE

6 nov 2024, 21:41 UTC

Utili

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 nov 2024, 21:40 UTC

Utili

Steris 2Q EPS $1.51 >STE

6 nov 2024, 21:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 nov 2024, 21:30 UTC

Utili

Steris 2Q Adj EPS $2.14 >STE

6 nov 2024, 21:30 UTC

Utili

Steris 2Q Rev $1.3B >STE

6 ago 2024, 20:36 UTC

Utili

Steris 1Q Adj EPS $2.03 >STE

6 ago 2024, 20:30 UTC

Utili

Steris 1Q Net $139.9M >STE

6 ago 2024, 20:30 UTC

Utili

Steris 1Q EPS $1.41 >STE

6 ago 2024, 20:30 UTC

Utili

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3 giu 2024, 11:03 UTC

Acquisizioni, Fusioni, Takeovers

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31 mag 2024, 20:47 UTC

Acquisizioni, Fusioni, Takeovers

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8 mag 2024, 20:40 UTC

Utili

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8 mag 2024, 20:39 UTC

Utili

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8 mag 2024, 20:39 UTC

Utili

Steris Announcing a Targeted Restructuring Plan >STE

8 mag 2024, 20:39 UTC

Utili

Steris 4Q EPS $3.81 >STE

8 mag 2024, 20:30 UTC

Utili

Steris 4Q Adj EPS $2.58 >STE

11 apr 2024, 11:01 UTC

Acquisizioni, Fusioni, Takeovers

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11 apr 2024, 11:00 UTC

Acquisizioni, Fusioni, Takeovers

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11 apr 2024, 10:59 UTC

Acquisizioni, Fusioni, Takeovers

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11 apr 2024, 10:59 UTC

Acquisizioni, Fusioni, Takeovers

Steris: Transaction Is Structured as Equity Sale >STE

11 apr 2024, 10:58 UTC

Acquisizioni, Fusioni, Takeovers

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11 apr 2024, 10:58 UTC

Acquisizioni, Fusioni, Takeovers

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Confronto tra pari

Modifica del prezzo

STERIS PLC Previsione

Obiettivo di Prezzo

By TipRanks

16.45% in crescita

Previsioni per 12 mesi

Media 265 USD  16.45%

Alto 265 USD

Basso 265 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per STERIS PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

222.25 / 228.22Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

73 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.